Robust immune response to SARS ‐ CoV ‐2 mRNA vaccines may exacerbate the clinical symptoms of A20 haploinsufficiency
- 1 January 2025
- journal article
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70065
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Safety of SARS-CoV-2 vaccination in patients with Behcet’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccineRheumatology International, 2022
- Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccineArthritis Research & Therapy, 2022
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3Journal of Clinical Immunology, 2020
- Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet’s diseaseArthritis Research & Therapy, 2019